Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer. | World J Gastrointest Oncol | 2022 | 36187390 | PubTator, text mining | PubMed |
| Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma. | Front Genet | 2022 | 36186458 | PubTator, text mining | PubMed |
| GBP2 as a potential prognostic predictor with immune-related characteristics in glioma. | Front Genet | 2022 | 36186425 | PubTator, text mining | PubMed |
| GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. | J Clin Lab Anal | 2022 | 36181310 | PubTator, text mining | PubMed |
| Insight into the pulmonary molecular toxicity of heated tobacco products using human bronchial and alveolar mucosa models at air-liquid interface. | Sci Rep | 2022 | 36180488 | PubTator, text mining | PubMed |
| Expression of ICOS in the salivary glands of patients with primary Sjogren's syndrome and its molecular mechanism. | Mol Med Rep | 2022 | 36177915 | PubTator, text mining | PubMed |
| PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC. | Comput Math Methods Med | 2022 | 36176741 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals T-cell exhaustion in denosumab-treated giant cell tumor of bone. | Front Immunol | 2022 | 36172351 | PubTator, text mining | PubMed |
| Time and age dependent regulation of neuroinflammation in a rat model of mesial temporal lobe epilepsy: Correlation with human data. | Front Cell Dev Biol | 2022 | 36172274 | PubTator, text mining | PubMed |
| Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients. | Front Genet | 2022 | 36171881 | PubTator, text mining | PubMed |
| Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer. | Aging (Albany NY) | 2022 | 36170029 | PubTator, text mining | PubMed |
| Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches. | Struct Chem | 2022 | 36160688 | PubTator, text mining | PubMed |
| Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors. | Front Genet | 2022 | 36159971 | PubTator, text mining | PubMed |
| High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer. | Front Genet | 2022 | 36159964 | PubTator, text mining | PubMed |
| Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19. | Front Immunol | 2022 | 36159873 | PubTator, text mining | PubMed |
| Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma. | Front Oncol | 2022 | 36158683 | PubTator, text mining | PubMed |
| Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models. | World J Gastroenterol | 2022 | 36157936 | PubTator, text mining | PubMed |
| Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach. | Sci Rep | 2022 | 36156077 | PubTator, text mining | PubMed |
| Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity. | Nat Commun | 2022 | 36153324 | PubTator, text mining | PubMed |
| Multiple Perspectives Reveal the Role of DNA Damage Repair Genes in the Molecular Classification and Prognosis of Pancreatic Adenocarcinoma. | Int J Mol Sci | 2022 | 36142142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=35